Flocor allows the red blood cells to flow more freely and lessens blockages that create crises. The study will provide half of the patients with Flocor and the other half with a placebo. The infusions are coded, a technique that ensures the accuracy of the test results, so that neither the investigators nor the patients will know who is receiving the drug. All patients will receive conventional treatment, including pain medication, for their crises. Eligible participants will be provided physical examinations by board-certified dermatologists, laboratory tests and medication at no cost.
Some programs have monetary compensation.
A second study is in need of volunteers age 18 and older to participate in a seven-month research study for the treatment of scalp psoriasis. To be eligible to participate in the study, volunteers must be males in good physical health between the ages of 45 and 65, have been diagnosed with high blood pressure, have a steady partner and have concerns related to sexual function. Participants will receive free study medication and office visits, physical exams and lab procedures. New Oral Drug for Hyperparathyroidism Volunteers who have been diagnosed with primary hyperparathyroidism are needed to participate in a five-week clinical research study to evaluate a new oral drug, Gallium Maltolate. To be eligible, the participants must not have had any therapy to treat hypercalcemia for at least eight weeks prior to participating in this study.